HIGHLIGHTS
- who: Mélusine Durand et al. from the Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, EFS, Infectious and Tropical Diseases Department, Caremeau University Hospital, Nîmes, France have published the research work: Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs, in the Journal: (JOURNAL)
- what: The authors aimed to ascertain the genotoxicity of DAA treatments consisting of different combinations of sofosbuvir, daclatasvir, and ribavirin, among PWID. The analysis showed that ‘being cotreated with ARV' and ‘methadone use' were positively associated with high accumulation of MDD in PWID . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.